Stubborn plantar warts have an answer.

Clinical studies show SWIFT clears plantar warts in approximately 75 to 80 percent of patients, including warts that have failed other treatments. Most patients require 3 to 4 sessions spaced 4 weeks apart. Effectiveness is particularly high for stubborn warts that haven't responded to standard care.

SWIFT's mechanism — triggering an immune response rather than physically destroying tissue — explains why it often works for warts that have resisted other treatments. The body's immune system can clear viral tissue that physical treatments cannot effectively reach. For some patients, SWIFT clears multiple warts even when only one was directly treated, because the immune response targets all wart tissue. We're honest about expected outcomes for your specific situation.

SWIFT treatment involves brief sharp heat sensations lasting only seconds with each pulse. Most patients describe the discomfort as significant but very brief — much shorter than cryotherapy treatment and without the days of post-treatment soreness common with freezing. No anesthesia is required.

Each pulse lasts about 2 seconds, with several pulses delivered per wart per session. The total discomfort time is brief. Most patients tolerate the treatment well, particularly given that SWIFT often succeeds for warts that have resisted years of other treatments. For patients with low pain tolerance, we use techniques to minimize discomfort. Most patients consider the brief discomfort worthwhile for the chance to finally clear stubborn warts.

Most patients require 3 to 4 SWIFT sessions spaced 4 weeks apart for optimal results. Some warts clear after fewer sessions; others require additional treatments. The 4-week spacing allows time for the immune response to develop and the body to begin clearing the wart tissue between treatments.

Treatment response builds over weeks as the immune system progressively clears the viral tissue. Patients often notice the first signs of improvement (color change, reduced thickness, decreased size) several weeks after the first or second treatment. The full course allows for continued immune stimulation until the wart is completely cleared. We track response at each session and adjust the plan if needed.

Yes — SWIFT has an excellent safety profile. The microwave energy is precisely controlled and limited to the wart tissue, with no systemic effects, no significant risk to surrounding healthy tissue, and no risk of disease transmission. Common side effects are limited to brief discomfort during treatment.

SWIFT doesn't break the skin, doesn't require systemic medications, and doesn't create wounds that can become infected. The treatment is approved for use in podiatry and dermatology and has been used successfully for many years internationally. Our team is fully trained in proper SWIFT technique and patient selection. We screen for the rare contraindications before treatment to ensure SWIFT is appropriate for your specific situation.

Most insurance plans don't cover SWIFT specifically, often considering it elective or experimental. Self-pay rates are typically reasonable, particularly compared to repeated cycles of less effective treatments. HSA and FSA accounts can usually be used for SWIFT treatment.

We discuss costs upfront before recommending SWIFT so you can make an informed decision. For patients comparing SWIFT to other options, we walk through the realistic expectations for each — sometimes a few rounds of in-office cryotherapy is the right next step before considering SWIFT, sometimes SWIFT is clearly the appropriate choice. The cost-effectiveness calculation often favors SWIFT for warts that have already failed multiple other treatments.